Discrepancy between the tuberculin skin test and the whole-blood interferon γ assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country

被引:352
作者
Kang, YA
Lee, HW
Yoon, HI
Cho, BL
Han, SK
Shim, YS
Yim, JJ
机构
[1] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul 110744, South Korea
[2] Seoul Natl Univ, Coll Med, Lung Inst, Seoul 110744, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Family Med, Seoul 110744, South Korea
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2005年 / 293卷 / 22期
关键词
D O I
10.1001/jama.293.22.2756
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context A recently developed whole-blood interferon gamma (IFN-gamma) assay based on stimulation with the Mycobacterium tuberculosis-specific antigens early secreted antigenic target 6 and culture filtrate protein 10 shows promise for the diagnosis of latent tuberculosis (TB) infection. Objective To compare the tuberculin skin test (TST) and the whole-blood IFN-gamma assay in the diagnosis of latent TB infection according to the intensity of exposure. Design and Setting A prospective comparison between the whole-blood IFN-gamma assay and the TST using a 2-TU dose of purified protein derivative RT23 in a population with intermediate TB burden was conducted sequentially between February 1, 2004, and February 28, 2005, in a Korean tertiary referral hospital. Participants Of 273 participants, 220 (95.7%) had received BCG vaccine. Participants were grouped according to their risk of infection: group 1, no identifiable risk of M tuberculosis infection (n = 99); group 2, recent casual contacts (n = 72); group 3, recent close contacts (n = 48); group 4, bacteriologically or pathologically confirmed TB patients (n = 54). Main Outcome Measures Levels of agreement between the TST and the IFN-gamma assay and the likelihood of infection in the various groups. Results For the TST with a 10-mm induration cutoff, the positive response rate in group 1 was 51%; group 2, 60%; group 3, 71%, and group 4, 78%. For the IFN-gamma assay, the positive response rate in group 1 was 4%; group 2, 10%; group 3, 44%; and group 4, 81%. The overall agreement between the TST and the IFN-gamma assay in healthy volunteers was kappa = 0.16. The odds of a positive test result per unit increase in exposure across the 4 groups increased by a factor of 5.31 (95% confidence interval [01, 3.62-7.79) for the IFN-gamma assay and by a factor of 1.52 (95% Cl, 1.20-1.91) for the TST (P<.001). Using a 15-mm induration cutoff for the TST did not make a substantial difference to the test results. Conclusion The IFN-gamma assay is abetter indicator of the risk of M tuberculosis infection than TST in a BCG-vaccinated population.
引用
收藏
页码:2756 / 2761
页数:6
相关论文
共 35 条
[1]  
*AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, pS221, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_
[2]   Specific immune-based diagnosis of tuberculosis [J].
Andersen, P ;
Munk, ME ;
Pollock, JM ;
Doherty, TM .
LANCET, 2000, 356 (9235) :1099-1104
[3]   Detection and identification of non-tuberculous mycobacterial infections in 6,472 tuberculosis suspected patients [J].
Bahrmand, AR ;
Madani, H ;
Samar, G ;
Khalilzadeh, L ;
Bakayev, VV ;
Yaghli, M ;
Babaei, MH .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1996, 28 (03) :275-278
[4]   Comparative genomics of BCG vaccines by whole-genome DNA microarray [J].
Behr, MA ;
Wilson, MA ;
Gill, WP ;
Salamon, H ;
Schoolnik, GK ;
Rane, S ;
Small, PM .
SCIENCE, 1999, 284 (5419) :1520-1523
[5]   Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts [J].
Brock, L ;
Weldingh, K ;
Lillebaek, T ;
Follmann, F ;
Andersen, P .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (01) :65-69
[6]   European framework for tuberculosis control and elimination in countries with a low incidence - Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) working group [J].
Broekmans, JF ;
Migliori, GB ;
Rieder, HL ;
Lees, J ;
Ruutu, P ;
Loddenkemper, R ;
Raviglione, MC .
EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (04) :765-775
[7]   The growing burden of tuberculosis - Global trends and interactions with the HIV epidemic [J].
Corbett, EL ;
Watt, CJ ;
Walker, N ;
Maher, D ;
Williams, BG ;
Raviglione, MC ;
Dye, C .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (09) :1009-1021
[8]   Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RDI immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6 [J].
Demangel, C ;
Brodin, P ;
Cockle, PJ ;
Brosch, R ;
Majlessi, L ;
Leclerc, C ;
Cole, ST .
INFECTION AND IMMUNITY, 2004, 72 (04) :2170-2176
[9]   Global burden of tuberculosis - Estimated incidence, prevalence, and mortality by country [J].
Dye, C ;
Scheele, S ;
Dolin, P ;
Pathania, V ;
Raviglione, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07) :677-686
[10]   Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak [J].
Ewer, K ;
Deeks, J ;
Alvarez, L ;
Bryant, S ;
Waller, S ;
Andersen, P ;
Monk, P ;
Lalvani, A .
LANCET, 2003, 361 (9364) :1168-1173